Jennison Associates
North America, New York, United States, New York
Description
Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969.
Investor Profile
Jennison Associates has made 27 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series B (26%)
- Post Ipo Equity (22%)
- Series C (15%)
- Series D (11%)
- Series Unknown (7%)
- Private Equity (7%)
- Convertible Note (4%)
- Series F (4%)
- Series E (4%)
Country Focus
- United States (93%)
- France (4%)
- Canada (4%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Genetics
- Biopharma
- Health Diagnostics
- Medical Device
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
